These results suggest that COE can inhibit lipid metabolism enzyme (FAS and LIPA) activities to restore the disordered lipid metabolism in hyperlipidemia (Evans et al. 2019; Jones and Infante 2015). This evidence concerns the gene FAS and hyperlipidemia.